The biotech firm priced 307,692 shares to raise gross proceeds of $2 million, with shares climbing nearly 18% in early trading.
Jupiter Neurosciences (JUNS) priced a registered direct offering of 307,692 shares of common stock at $6.10 per share, raising approximately $2 million in gross proceeds. The offering is expected to close on or around August 24.
Shares of the company surged nearly 18% following the announcement. The offering follows recent market activity, though no prior consensus or comparable period was disclosed for this specific raise.
The company did not provide additional details on the use of proceeds or immediate market reaction beyond the share price movement.